A complete copy of the gene (cpe) encoding Clostidium perfingens enterotoxin (CPE), an important virulence factor involved in C. perfringens food poisoning and other gastrointestinal illnesses, has been cloned, sequenced, and expressed in Escherichia coli. The cpe gene was shown to encode a 319-amino-acid polypeptide with a deduced molecular weight of 35,317. There was no consensus sequence for a typical signal peptide present in the 5' region of cpe. Cell lysates from recombinant cpe-positive E. coli were shown by quantitative immunoblot analysis to contain moderate amounts of CPE, and this recombinant CPE was equal to native CPE in cytotoxicity for mammalian Vero cells. CPE expression in recombinant E. coli appeared to be largely driven from a clostridial promoter. Immunoblot analysis also demonstrated very low levels of CPE in vegetative cell lysates of enterotoxin-positive C. perfringens. However, when the same C. perfringens strain was induced to sporulate, much stronger CPE expression was detected in these sporulating cells than in either vegetative C. perfringens cells or recombinant E. coli. Collectively, these results strongly suggest that sporulation is not essential for cpe expression, but sporulation does facilitate high-level cpe expression. Clostridium perfringens ranks among the most important of the anaerobic bacterial pathogens for humans and domestic animals, causing myonecrosis (gas gangrene), anaerobic cellulitis, septicemia, uterine infections, and gastrointestinal illnesses (28). The virulence of this endospore-forming, gram-positive bacterium results from its prolific ability to produce protein toxins (28). Among the 13 types of toxins known to be produced by this organism is C. perfringens enterotoxin (CPE), which is a single polypeptide of 35 kDa with a unique amino acid sequence (9, 23, 24, 28). CPE causes the symptoms associated with C. perfringens type A food poisoning, which is among the most common human food-borne illnesses (23, 24, 28), and it also appears to be involved in other important human and veterinary gastrointestinal illnesses (2, 5, 24). Recent studies (11, 15, 26, 27, 43) have shown CPE action to involve sequentially (i) specific binding of enterotoxin to a proteinaceous receptor on mammalian membranes, (ii) insertion of CPE into plasma membranes, (iii) formation of a complex between enterotoxin and two mammalian membrane proteins of 70 and 50 kDa, (iv) production of membrane permeability alterations for small molecules such as ions, and (v) induction of secondary effects which culminate in cell death. CPE binding to mammalian receptors is mediated by a 30-amino-acid region at the extreme C terminus of enterotoxin (12, 14). Cytotoxicity also requires sequences in the N-terminal half of the enterotoxin, suggesting the existence of separate binding and cytotoxicity domains on CPE (13). Upon entering the human host, it is common for many bacterial pathogens to undergo global changes in gene expression (30). These changes often include de novo synthesis of virulence factors...